<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02142985</url>
  </required_header>
  <id_info>
    <org_study_id>ScvO2 Flo-Trac study</org_study_id>
    <nct_id>NCT02142985</nct_id>
  </id_info>
  <brief_title>Respiratory Variation in Central Venous Oxygen Saturation Predicts Volume Responsiveness in Hemodynamically Unstable Patients Under Mechanical Ventilation : a Prospective Cohort Study</brief_title>
  <acronym>VOS-HI</acronym>
  <official_title>Respiratory Variation in Central Venous Oxygen Saturation Predicts Volume Responsiveness in Hemodynamically Unstable Patients Under Mechanical Ventilation : a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Monastir</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Monastir</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vascular filling is the main treatment of hypovolemia. Hypovolemia diagnosis can be difficult&#xD;
      in some situations and need to be confirmed with other investigations.&#xD;
&#xD;
      Venous oxymetry based on the ScvO2 values represent a valuable way to predict responsivness&#xD;
      to fluid filling maneuver in patients with hemodynamic instability.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vascular filling represent the milestone of the treatment of hypovolemia. Its main objective&#xD;
      is to restore vascular volume and correct perfusion issues preventing the deleterious&#xD;
      consequences of prolonged shock.&#xD;
&#xD;
      Hypovolemia diagnosis is easy to made in obvious clinical situations such as hemorrhagic&#xD;
      shock, deshydratation..., but there still many diagnostic difficulties regarding latent&#xD;
      hypovolemia especially if associated with left ventricular dysfunction.&#xD;
&#xD;
      In this situations, diagnostic of hypovolemia is hard to made and other investigations are&#xD;
      needed.&#xD;
&#xD;
      Central venous pressure (CVP) and pulmonary occlusion artery pressure (PAPO) are the mainly&#xD;
      used parameters for indicating vascular filling but actually many studies underline their low&#xD;
      liability in this situation.&#xD;
&#xD;
      After vascular filling, outcome measurment is needed to evaluate the efficacity of the&#xD;
      treatment.&#xD;
&#xD;
      Outcome measurment based on hemodynamic criteria is still insufficient. In fact, tissue&#xD;
      hypoxia persists if the cardio - respiratory system did not adapt to the metabolic needs,&#xD;
      that's why a pathway based on therapeutic objectives like venous oxymetry is needed.&#xD;
&#xD;
      Theorically, a filling maneuver is beneficial if associated with a ScvO2 amelioration. It&#xD;
      reflects the amelioration of cardiac output and predicts the positive responsivness to the&#xD;
      filling test.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2014</start_date>
  <completion_date type="Actual">October 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>central venous oxygen saturation (ScvO2) variation</measure>
    <time_frame>at baseline and after 10 minutes</time_frame>
    <description>the ScvO2 is first measured at baseline via a central venous catheter and blood gaz, then after vascular filling (500 ml of colloid solution (Plasmagel) over thirty minutes).</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">88</enrollment>
  <condition>Hemodynamic Instability</condition>
  <arm_group>
    <arm_group_label>crystalloid solution</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>vascular filling with 500 ml of crystalloid solution within 10 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride 0.9% Intravenous</intervention_name>
    <description>vascular filling with 500 ml of crystalloid solution (sodium chloride 0.9%) over 30 minutes</description>
    <arm_group_label>crystalloid solution</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients aged above 18 year old&#xD;
&#xD;
          -  hemodynamic instability (hypotension or shock)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  intra cardiac shunt&#xD;
&#xD;
          -  severe arrythmia&#xD;
&#xD;
          -  valvular regurgitation&#xD;
&#xD;
          -  pacemaker&#xD;
&#xD;
          -  pulmonary oedema&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nouira Samir, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Research Laboratory (LR12SP18) University of Monastir 5000 Tunisia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency department of university hospital Fattouma Bourguiba of Monastir</name>
      <address>
        <city>Monastir</city>
        <zip>6000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <link>
    <url>http://www.urgencemonastir.com</url>
    <description>official website</description>
  </link>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>May 6, 2014</study_first_submitted>
  <study_first_submitted_qc>May 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2014</study_first_posted>
  <last_update_submitted>April 29, 2021</last_update_submitted>
  <last_update_submitted_qc>April 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Monastir</investigator_affiliation>
    <investigator_full_name>Pr. Semir Nouira</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

